American Board of Surgery
MD, Hospital of the University of Pennsylvania
Residency, General Surgery
Hospital of The University Of Penn.
Fellowship, Liver Transplant
UCLA Medical Center
Lerner SM. Hepatitis C and renal transplantation. The Mount Sinai journal of medicine, New York; 79(3).
Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, Gornbein J, Yersiz H, Morrissey M, Lerner SM, Mc Diarmid SV, Busuttil RW. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Tranplantation 2001 Sep 27; 72(6): 1113-22.
Lerner SM. Kidney and pancreas transplantation in type 1 diabetes mellitus. The Mount Sinai journal of medicine, New York 2008 Aug; 75(4).
Yersiz H, Renz JF, Hisatake G, Reichert PR, Feduska NJ Jr, Lerner SM, Farmer DG, Ghobrial RM, Geevarghese S, Baquerizo A, Chen P, Busuttil RW. Technical and logistical considerations of in situ split-liver transplantation for two adults: Part I. Creation of left segment II, III, IV and right segment I, V-VIII grafts. Liver Tranpl 2001 Dec; 7(12): 1077-80.
Yersiz H, Renz JF, Hisatake G, Reichert PR, Feduska NJ Jr, Lerner SM, Farmer DG, Ghobrial RM, Geevarghese S, Baquerizo A, Chen P, Busuttil RW. Technical and logistical considerations of in situ split-liver transplantation for two adults: Part II. Creation of left segment I-IV and right segment V-VIII grafts. Liver Transpl 2002 Jan; 8(1): 78-81.
Alfrey EJ, Boissy AR, Lerner SM. Dual-kidney transplants: long-term results. Transplantation 2003 Apr 27; 75(8): 1232-6.
Lerner SM, Hiatt JR, Salamandra J, Chen PW, Farmer DG, Ghobrial RM, Busuttil RW. Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004 Aug; 139(8): 818-21.
Lerner SM, Markmann J, Jurim O, Busuttil RW. Retransplantation. In: Busuttil RW, Klintmalm GB, editors. Transplantation of the Liver. 4th ed Philadelphia, W.B. Saunders, Co.; 2005.
Dick AA, Lerner SM, Boissy AR, Farrell CE, Alfrey EJ. Excellent outcome in infants and small children with thrombophilias undergoing kidney transplantation. Pediatr Transplant 2005 Feb; 9(1): 39-42.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Lerner has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.